• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

ALTERED GROWTH CONTROL OF HEPATOCYTES DURING THE CARCINOGENESIS AND ITS REGULATION

Research Project

Project/Area Number 09470138
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionOsaka University

Principal Investigator

KAWATA Sumio  Osaka University Medical School, Associate Professor, 医学部, 助教授 (90183285)

Co-Investigator(Kenkyū-buntansha) KISO Shinichi  Osaka University Hospital, Medical Staff, 医学部・附属病院, 医員
FUKUDA Kazuto  Osaka University Hospital, Medical Staff, 医学部・附属病院, 医員
TAMURA Shinji  Osaka University Medical School, Assistant Professor, 医学部, 助手 (30243223)
松田 幸彦  大阪大学, 医学部, 助手 (90283770)
Project Period (FY) 1997 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥7,200,000 (Direct Cost: ¥7,200,000)
Fiscal Year 1998: ¥2,500,000 (Direct Cost: ¥2,500,000)
Fiscal Year 1997: ¥4,700,000 (Direct Cost: ¥4,700,000)
KeywordsHepatocellular carcinoma / TGF-b / TGF-b receptor / gene mutation / cell growth
Research Abstract

We are studying on altered control on hepatocytes growth during the carcinogensis. The altered regulation seems to be derived from escape from negative growth control by TGF-b via , a loss of responsivity of hepatocytes. Our hypothesis is that ther is not only defect of TGF-b receptor but also alteration of the signal transduction pathway of the cytokine.
To determined wether Src kinase is involved in TGF-b signaling, we examined the effects of TGF-b1 on Src in rat fibroblast- cell line 3Y1 and in v-Src-transformed 3Y1 (SR-3Y1). TGF-b1 inhibited MAP kinase activity and inhibited growth in SR-3Y1 cells, while it did not affect the growth of 3Y1 cells. TGF-b1 significantly decreased v-Src kinase activity and protein abundance in SR-3Y1 cells, mainly by accelerating the degradation of v-Src. In contrast, in 3Y1 cells, TGF-b1 did not affect c-Src abandance or kinase activity. however, upon activation of c-Src in 3Y1 cells by PDGF, TGF-b1 decreased Src abundance. Additionally, in 3Y1 cells transfected with an activated c-Src mutant which lacks the SH3 domain, its level was decreased by TGF-b1 treatment. These findings suggest that TGf-b1 specifically induces degradation of activated Src kinase. This may be a novel mechanism for cross-talk between growth factors and TGF-b.

Report

(3 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • Research Products

    (29 results)

All Other

All Publications (29 results)

  • [Publications] K.Fukuda,S.Kawata,et al.: "Transforming growth factor-β induced degradation of activated Src tyrosine kinase in rat fibroblasts." Oncogene. 16. 3349-3356 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Fukuda,S.Kawata,et al.: "Altered regulation of Src tyrosine kinase by transforming growth factor-β in a human hepatoma cell line." Hepatology. 28. 796-804 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] H.Tsushima,S.kawata,et al.: "Reduced plasma TGF-β1 levels in patients with chronic hepatitis C after interferon-α." J.Hepatol.30. 1-7 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.Imai,S.kawata,et al.: "Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C." Ann.Intern.Med.129. 94-99 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] T.Nagase,S.kawata,et al.: "Effect of farnesyltransferase overexpression on cell growth and transformation." Int.J.Cancer. 80. 126-133 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] T.Nagase,S.Kawata,et al.: "Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth." Brit.J.Cancer. 76. 1001-1010 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 河田純男: "肝臓病学。ヒト肝癌と細胞増殖因子。" 医学書院, 904 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] 田村信司,河田純男: "がんの浸潤・転移。TGF-βとがんの発育,進展" 医学書院, 329 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Fukuda, S.Kawata, et al.: "Transforming growth factor-b induced degradation of activated Src tyrosine kinase in rat fibroblasts." Oncogene. 16. 3349-3356 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Fukuda, S.Kawata, et al.: "Altered regulation of Src tyrosine kinase by transforming growth factor-b in a human hepatoma cell line." Hepatology. 28. 796-804 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] H.Tsushima, S.Kawata, et al.: "Reduced plasma TGF-bl levels in patients with chronic hepatitis C after interferon-alpha." J.Hepatol. 30. 1-7 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Y.Imai, S.Kawata, et al.: "Effect of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C." Ann.Inern.Med.129. 94-99 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] T.Nagase, S.Kawata, et al.: "Effect of farnesy1-transferase overexpression on cell growth and transformation." Int.J.cancer. 80. 126-133 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] T.Nagase, S.Kawata, et al.: "Manumycin and gliotoxin derivatives KT7595 block Ras farnesylation and cell growth." Brit.J.Cancer. 76. 1001-1010 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] K.Fukuda, S.Kawata, et al.: "Transforming growth factor-β induced degradation of actirated Src tyrosine kinase in rat fibroblasts." Oncogene. 16. 3249-3356 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] K.Fukuda, S.Kawata, et al.: "Altered regulation of Src tyrosine kinase by transfoming growth factor-β in a human hepatoma cell line." Hepatology. 28. 796-804 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] H.Tsushima, S.Kawata, et al.: "Reduced plasma TGF-β1 levels in patients with chronic hepatitis C after interferon-α." J.Hepatol.30. 1-7 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Y.Imai, S.Kawata, et al.: "Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C." Ann.Intern.Med.129. 94-99 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] T.Nagase, S.Kawata, et al.: "Effect of farnesyl transferase over expression on cell growth and transformation." Int.J.Cancer. 80. 126-133 (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] T.Nagase, S.Kawata, et al.: "Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth." Brit.J.Cancer. 76. 1001-1010 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] 河田純男: "肝臓病学。ヒト肝癌と細胞増殖因子。" 医学書院, 904 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 田村信司,河田純男: "ガスの浸潤・転移。TGF-βとがんの発育、進展" 医学書院, 329 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] N.Ito, S.Kawata, et al.: "Increased circulating TGF-β in a patient with giant hepatic hemangioma" Hepatology. 25(1). 93-96 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] T.Nagase, S.Kawata: "Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth." Brit. J. Cancer. 76(8). 1001-1010 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] K.Fukuda, S.Kawata, et al.: "TGF-β1-induced degradation of activated Sre tyrosine kinase in rat fibroblast." Oncogene. (印刷中).

    • Related Report
      1997 Annual Research Report
  • [Publications] S.Kiso, S.Kawata, et al.: "Efficacy of combined theory of interferon-α with ursodeoxy-chelic acid in chronic hepatitis C." J. Gastroenterol.32(1). 56-62 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Y.Imai, S.Kawata, et al.: "Recombinant interferon-α_2a for treatment of chronic hepatitis C." Livor. 17. 88-92 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] E.Shinohara, S.Kawata, et al.: "Interferon-α induces disorder of lipid metabolism by for using pastheparin lipases and CETP activities in chronic hepatitis C." Hepatology. 25(6). 1502-1506 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] 津島博史, 河田純男: "動脈硬化研究ストラテジー。TGF-β" 秀潤社, 300 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi